|
1
|
Von Boros J and Korenyi A: Uber einen fall
von akuter megakaryocyblasten-leukamie, zugleich einige bemerkungen
zum Problem der akuten leukemie. Z Klin Med. 118:679–718. 1931.(In
German).
|
|
2
|
Breton-Gorius J, Reyes F, Duhamel G,
Najman A and Gorin NC: Megakaryoblastic acute leukemia:
Identification by the ultrastructural demonstration of platelet
peroxidase. Blood. 51:45–60. 1978.PubMed/NCBI
|
|
3
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Criteria for the
diagnosis of acute leukemia of megakaryocyte lineage (M7). A report
of the French-American-British Cooperative Group. Ann Intern Med.
103:460–462. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H, Thiele J and Vardiman JW: WHO Classification of
Tumours of Haematopoietic and Lymphoid Tissues. 4th edition. Lyon:
pp. 136–137. 2008
|
|
5
|
den Ottolander GJ, te Velde J, Brederoo P,
Geraedts JP, Slee PH, Willemze R, Zwaan FE, Haak HL, Muller HP and
Bieger R: Megakaryoblastic leukaemia (acute myelofibrosis): A
report of three cases. Br J Haematol. 42:9–20. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Strauchen JA: Criteria for the diagnosis
of acute megakaryocytic leukemia. Blood. 97:18982001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shibata A, Bennett JM, Castoldi GL,
Catovsky D, Flandrin G, Jaffe ES, Katayama I, Nanba K, Schmalzl F,
Yam LT, et al: Recommended methods for cytological procedures in
haematology. International committee for standardization in
haematology (ICSH). Clin Lab Haematol. 7:55–74. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gruppo RA, Lampkin BC and Granger S: Bone
marrow cellularity determination: Comparison of the biopsy,
aspirate, and buffy coat. Blood. 49:29–31. 1977.PubMed/NCBI
|
|
9
|
Thiele J, Kvasnicka HM, Facchetti F,
Franco V, van der Walt J and Orazi A: European consensus on grading
bone marrow fibrosis and assessment of cellularity. Haematologica.
90:1128–1132. 2005.PubMed/NCBI
|
|
10
|
Gonzalez GJ and Meza-Espinoza JP: Use of
the International System for Human Cytogenetic Nomenclature (ISCN).
Blood. 108:3952–3953. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jones AV, Kreil S, Zoi K, Waghorn K,
Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, et al:
Widespread occurrence of the JAK2 V617F mutation in chronic
myeloproliferative disorders. Blood. 106:2162–2168. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pagano L, Pulsoni A, Vignetti M, Mele L,
Fianchi L, Petti MC, Mirto S, Falcucci P, Fazi P, Broccia G, et al:
Acute megakaryoblastic leukemia: Experience of GIMEMA trials.
Leukemia. 16:1622–1626. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tallman MS, Neuberg D, Bennett JM,
Francois CJ, Paietta E, Wiernik PH, Dewald G, Cassileth PA, Oken MM
and Rowe JM: Acute megakaryocytic leukemia: The Eastern Cooperative
Oncology Group experience. Blood. 96:2405–2411. 2000.PubMed/NCBI
|
|
14
|
Duchayne E, Fenneteau O, Pages MP, Sainty
D, Arnoulet C, Dastugue N, Garand R and Flandrin G: GroupeFrançais
d'Hématologie Cellulaire; Groupe Français de Cytogénétique
Hématologique: Acute megakaryoblastic leukaemia: A national
clinical and biological study of 53 adult and childhood cases by
the Groupe Francais d'Hematologie Cellulaire (GFHC). Leuk Lymphoma.
44:49–58. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oki Y, Kantarjian HM, Zhou X, Cortes J,
Faderl S, Verstovsek S, O'Brien S, Koller C, Beran M, Bekele BN, et
al: Adult acute megakaryocytic leukemia: An analysis of 37 patients
treated at M.D. Anderson Cancer Center. Blood. 107:880–884. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahmad F, Dalvi R, Das BR and Mandava S:
Novel t(8;17)(q23; q24.2) and t(9;22) (p24.1;q12.2) in acute
megakaryoblastic leukemia AML-M7 subtype in an adult patient.
Cancer Genet Cytogenet. 193:112–115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang E and Stoecker M: ‘Cannibalistic’
phagocytosis in acute megakaryoblastic leukemia (AML M7) with
t(10;17) (p15; q22). Leuk Lymphoma. 51:1944–1947. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hahn AW, Li B, Prouet P, Giri S, Pathak R
and Martin MG: Acute megakaryocytic leukemia: What have we learned.
Blood Rev. 30:49–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Druker BJ: Translation of the Philadelphia
chromosome into therapy for CML. Blood. 112:4808–4817. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Karkuzhali P, Shanthi V and Usha T: A case
of chronic myeloid leukaemia presenting as megakaryocytic blast
crisis (AML M7). Ecancermedicalscience. 7:3752013.PubMed/NCBI
|
|
21
|
Akahoshi M, Oshimi K, Mizoguchi H, Okada
M, Enomoto Y and Watanabe Y: Myeloproliferative disorders
terminating in acute megakaryoblastic leukemia with chromosome 3q26
abnormality. Cancer. 60:2654–2661. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Radaelli F, Mazza R, Curioni E, Ciani A,
Pomati M and Maiolo AT: Acute megakaryocytic leukemia in essential
thrombocythemia: An unusual evolution. Eur J Haematol. 69:108–111.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mesa RA, Li CY, Kettering RP, Schroeder
GS, Knudson RA and Tefferi A: Leukemic transformation in
myelofibrosis with myeloid metaplasia: A single-institution
experience with 91 cases. Blood. 105:973–977. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vianelli N, Baravelli S and Gugliotta L:
Acute megakaryoblastic transformation of essential thrombocythemia.
Haematologica. 81:288–289. 1996.PubMed/NCBI
|
|
25
|
Patiño-Sarcinelli F, Knecht H, Pechet L,
Pihan G, Savas L and Snyder LM: Leukemia with megakaryocytic
differentiation following essential thrombocythemia and
myelofibrosis. Case report and review of the literature. Acta
Haematol. 95:122–128. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Swaminathan S, Madkaikar M, Ghosh K,
Vundinti BR, Kerketta L and Gupta M: Novel immunophenotypic and
morphologic presentation in acute myeloid leukemia (AML) with JAK2
V617F mutation. Eur J Haematol. 84:180–182. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giri S, Pathak R, Prouet P, Li B and
Martin MG: Acute megakaryocytic leukemia is associated with worse
outcomes than other types of acute myeloid leukemia. Blood.
124:3833–3834. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garderet L, Labopin M, Gorin NC, Polge E,
Baruchel A, Meloni G, Ortega J, Vossen J, Bunjes D, Leverger G, et
al: Hematopoietic stem cell transplantation for de novo acute
megakaryocytic leukemia in first complete remission: A
retrospective study of the European Group for Blood and Marrow
Transplantation (EBMT). Blood. 105:405–419. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishiyama K, Yamaguchi T, Eto T, Ohashi K,
Uchida N, Kanamori H, Fukuda T, Miyamura K, Inoue Y, Taguchi J, et
al: Acute megakaryoblastic leukemia, unlike acute erythroid
leukemia, predicts an unfavorable outcome after allogeneic HSCT.
Leuk Res. 47:47–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
